What are the factors that affect post COVID 1st month's continuing symptoms?
Open Access
- 12 September 2021
- journal article
- research article
- Published by Hindawi Limited in International Journal Of Clinical Practice
- Vol. 75 (11) , e14778
Abstract
Aim The aim of our research was to investigate retrospectively the relationship between the symptoms and general characteristics, initial laboratory values and treatments in patients who had COVID- 19 and who applied to the chest diseases outpatient clinic for control after 1 month. Methods Three hundred fifteen patients who were diagnosed with COVID- 19 and applied to the chest diseases outpatient clinic between May 2020 and August 2020 for control in the 1st month were included in the study. Patient information was collected from the hospital information system and the e-pulse system. Results Females accounted for 50.2 % of the our patients and their mean age was 47.9 ± 14.8 (19-88) years. 14.3% (n: 45) of the individuals were 65 years of age and older. 20.6% (n: 65) of our patients were smoking. 70.2% (n: 221) of our patients were treated at home. 133 patients had at least one comorbid disease. The patients most frequently reported cough, dyspnea, weakness, myalgia and diarrhea. The most common symptoms were cough, dyspnea, weakness and myalgia in the first month. Initial D-dimer, initial CRP and the values of platelet, D dimer and CRP in the first month were detected to be higher in patients with persistens symptoms when the laboratory values of patients whose symptoms continue after 1 month were examined. It was determined that the symptoms had persisted in patients who had been hospitalized, had dual therapy, had comorbid diseases and had more common pathologies in their pulmonary imagings. Conclusion Symptoms may persist for a long time in hospitalized patients, in patients with COVID-19-related pneumonia and concomitant chronic diseases and in patients with high D-dimer and high CRP at the time of admission. Patients are informed that their symptoms may last for a long time, unnecessary hospital admissons can be avoided.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Drug treatment options for the 2019-new coronavirus (2019-nCoV)BioScience Trends, 2020
- [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China].2020
- Epidemiologic characteristics of early cases with 2019 novel coronavirus (2019-nCoV) disease in KoreaEpidemiology and Health, 2020
- Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019‐nCoVChemBioChem, 2020
- A pneumonia outbreak associated with a new coronavirus of probable bat originNature, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- COVID-19 Infection Presenting with CT Halo SignRadiology: Cardiothoracic Imaging, 2020
- Sexual Dimorphism in Innate ImmunityClinical Reviews in Allergy & Immunology, 2017
- Imaging of Pulmonary Viral PneumoniaRadiology, 2011